Skip to content
healthcare.dev

Pancreas DB Liquescence 3037

NDC 63083-3037, Pancreas DB Liquescence, liquid, from Professional Complementary Health Formulas.

Product NDC
63083-3037
Status
Listed
Labeler
Professional Complementary Health Formulas
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63083-3037 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRILLIUM ERECTUM ROOT1 [hp_X]/118mL
  • FENUGREEK SEED3 [hp_X]/118mL
  • GYMNEMA SYLVESTRE LEAF3 [hp_X]/118mL
  • PHOSPHORIC ACID3 [hp_X]/118mL
  • RHUS AROMATICA ROOT BARK3 [hp_X]/118mL
  • SYZYGIUM CUMINI SEED3 [hp_X]/118mL
  • SILVER NITRATE6 [hp_X]/118mL
  • CHIONANTHUS VIRGINICUS BARK6 [hp_X]/118mL
  • PHOSPHORUS6 [hp_X]/118mL
  • ZINC6 [hp_X]/118mL
  • BOS TAURUS PANCREAS6 [hp_X]/118mL
  • CHROMIUM8 [hp_X]/118mL
  • SULFUR8 [hp_X]/118mL
  • VANADIUM8 [hp_X]/118mL
  • LYCOPODIUM CLAVATUM SPORE8 [hp_X]/118mL
  • HEXAPLEX TRUNCULUS HYPOBRANCHIAL GLAND JUICE12 [hp_X]/118mL
  • INSULIN GLULISINE30 [hp_X]/118mL
  • URANYL NITRATE HEXAHYDRATE30 [hp_X]/118mL

Pharmacologic classes

Allergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Insulin Analog [EPC]; Insulin [Chemical/Ingredient]; Standardized Chemical Allergen [EPC]

Package NDCNDC-11Package
63083-3037-463083303704118 mL in 1 BOTTLE, DROPPER (63083-3037-4)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 63083-3037 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63083-3037 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63083-3037. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.